The AlphaVax pipeline is targeting pandemic influenza and cytomegalovirus (CMV), as well as grant and collaborator-supported programs in HIV, prostate and breast cancer, and several biodefense vaccines. Clinical data from the first alphavaccine human trials have confirmed safety and immunological activity in man. These immune responses are characterized as robust and balanced antibody (B-cell) and cellular (T-cell) immune responses, confirming the promising data we have obtained in over a decade of intensive pre-clinical work with this vector platform.
Company Details
- Address
- 2 Triangle Drive,
- Phone
- 919-595-0400
- fi****@****vax.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- alphavax.com
- Keywords
- alphavirus and vaccine.
- HQ
- Research Triangle Park, NC
Alphavax Questions
Alphavax's helpline number is 919-595-0400
Alphavax's website is alphavax.com
Alphavax's LinkedIn profile is https://www.linkedin.com/company/alphavax
Alphavax's industry is
Biotechnology Research
Alphavax's top competitors are
Achelios Therapeutics,
Angiodynamics,
Cytodel Inc,
Genomatix Ag,
Novo Nordisk,
Xoventure Life Science Experts,
Aerial Biopharma Llc,
Algentech Sas,
Aktis Oncology,
Globeimmune, Inc..
Alphavax's support email address is finance@alphavax.com
Alphavax's categories are Biotechnology Research
